› $150,000,000 verdict in personal injury case
Millions of people turn to medication to treat the annoying and painful symptoms of heartburn. But doctors say that people who use medications to treat their symptoms should use them with caution and limit use if at all possible.
Last month, a 12-year-old girl’s mysterious sneezing illness promoted a flurry of attention after her story was told on MSNBC’s Today show. Lauren Johnson sneezes 10 times a minute – up to 12,000 of times a day – and doctors have no clue why. Weeks later she was diagnosed with Paediatric Autoimmune Neuropsychiatric Disorder Associated with Streptoccus, or PANDAS. Her parents say that antibiotics have improved her disorder, but that she is at risk of showing symptoms again in the future.
When Joey* was two months old, he was prescribed Reglan (known generically as metoclopramide) and took the medication for two years. When Joey turned 5, he began blinking his eyes uncontrollably. Less than two years later, he was still blinking uncontrollably but he also began jerking his head. “The doctors at first thought my son had Tourette’s syndrome,” says Joey’s mother on a post on iGuard about Reglan. “But now after knowing the side effects of Reglan they are starting to think he has permanent Tardive Dyskinesia.”
Kecia Neal of Arkansas was prescribed Reglan in 2005 to help her overcome a medical condition that involved the paralysis of stomach muscles. What she didn’t expect is for the medication to make her even sicker.
Karter’s parents want to know if their infant son has Tardive Dyskinesia (TD). The little guy thrusts his body around and cries constantly for several minutes as his family watches helplessly. They posted this video, called Is this Tardive Dyskinesia, just four weeks ago on YouTube seeking answers.
A Missouri woman is seeking more than $600,000 in damages from the makers of Reglan (metoclopramide) for not adequately warning her of the risk of a serious, permanent, disabling neurological condition known as Tardive Dyskinesia.
Questcor Pharmaceuticals Inc. has just released the study results of its Phase II clinical trial on a metoclopramide nasal spray for the treatment of diabetic gastroparesis, a condition in which contents remain in the stomach for a longer period of time than normal. Left untreated, gastroparesis can lead to fluctuations in blood glucose, general malnutrition, intestinal obstruction and bacterial infection.
Laura Tennant wants answers. The former editor of the Leader-Courier was prescribed Reglan more than a year ago to treat a digestive disorder. Now she appears to be suffering from what she calls “permanent central nervous system damage.”
Warner Chilcott, the makers of Sarafem (fluoxetine hydrochloride), a treatment for Premenstrual Dysphoric Disorder (PMDD), have issued a warning about the risk of neuroleptic malignant syndrome, also known as Tardive Dyskinesia, a condition in which a person develops involuntary movements of his muscles similar to Parkinson’s Disease.
Nursing mothers who have difficulty establishing or maintaining breast milk production may be prescribed medication to increase the amount of breast milk they produce. One popular choice has been metoclopramide, most commonly known as Reglan.
